1-3 of 3
Ron H.J. Mathijssen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Darolutamide Added to Docetaxel Augments Antitumor Effect in Models of Prostate Cancer through Cell Cycle Arrest at the G1–S Transition

Stefan A.J. Buck, Annelies Van Hemelryk, Corrina de Ridder, Debra Stuurman, Sigrun Erkens-Schulze, Sem van ’t Geloof, Wilma J. Teubel, Stijn L.W. Koolen, Elena S. Martens-Uzunova, Martin E. van Royen, Ronald de Wit, Ron H.J. Mathijssen, Wytske M. van Weerden
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2024) 23 (5): 711–720.
https://doi.org/10.1158/1535-7163.MCT-23-0420
Published: 02 May 2024
View article titled, Darolutamide Added to Docetaxel Augments Antitumor Effect in Models of Prostate Cancer through Cell Cycle Arrest at the G<sub>1</sub>–S Transition
Open the PDF for Darolutamide Added to Docetaxel Augments Antitumor Effect in Models of Prostate Cancer through Cell Cycle Arrest at the G<sub>1</sub>–S Transition in another window
Includes: Supplementary data
Journal Articles

Abstract A99: Docetaxel-resistance can be overcome by enhancing intratumoral taxane concentrations to a threshold level for efficacy.

Ellen S. de Morree, Corrina M. de Ridder, Peter de Bruijn, Herman Burger, Erik A.C. Wiemer, Ron H.J. Mathijssen, Ronald de Wit, Wytske van Weerden
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2013) 12 (11_Supplement): A99.
https://doi.org/10.1158/1535-7163.TARG-13-A99
Published: 01 November 2013
View article titled, Abstract A99: Docetaxel-resistance can be overcome by enhancing intratumoral taxane concentrations to a threshold level for efficacy.
Journal Articles

Abstract C118: Influence of CYP2D6 phenotype on tamoxifen‐treatment outcome in women with metastatic breast cancer

Laureen A. Lammers, Ron H.J. Mathijssen, Teun van Gelder, Monique J. Bijl, Anne‐Joy M. de Graan, Caroline Seynaeve, Marianne van Fessem, Els M. Berns, Arnold G. Vulto, Ron H. van Schaik
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (12_Supplement): C118.
https://doi.org/10.1158/1535-7163.TARG-09-C118
Published: 10 December 2009
View article titled, Abstract C118: Influence of CYP2D6 phenotype on tamoxifen‐treatment outcome in women with metastatic breast cancer